Mach7 Technologies Ltd. · ASX:M7T
Mach7 Technologies — Shareholder Meeting (November 2021)
12 slides from Mach7 Technologies's shareholder meeting presentation, Nov 11, 2021
Slide 1: Mach7 Annual General Meeting
Mach7 Annual General Meeting 11 November 2021
Slide 2: CEO Presentation
CEO PRESENTATION Mr Mike Lampron
Slide 3: “Mach7” - who we are
“Mach7” - who we are Our Solutions FY21 in Review FY22 so Far The Future
Slide 4: More than 150 customers spanning 15 countries
More than 150 customers spanning 15 countries Hospitals and healthcare entities around the world deploy Mach7’s solutions and innovative technologies. We have built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research
Slide 5: An enterprise-wide, interoperable platform
An enterprise-wide, interoperable platform for storing, retrieving and viewing all medical imaging data in one vendor neutral ecosystem. Consisting of: • Enterprise Data Management • Enterprise Diagnostic Viewing • Enterprise PACS
Slide 6: At Mach7, we provide an Enterprise Imaging Platform
At Mach7, we provide an Enterprise Imaging Platform, that provides: Consolidation of all Access all images PACS solution images We then enable access to this The enterprise platform can be At the core of this platform is a data to enterprise users used as a diagnostic PACS Vendor Neutral Archive whi
Slide 7: AI Current Market State
AI Current Market State Mach7’s Visualization and Initiatives for AI • AI is still maturing but has gained traction during pandemic especially in • Mach7 has partnership with Nuance Communications to empower AI understanding COVID-19 to expedite drug discovery within Radiology reading workflow to dr
Slide 8: Key Achievements FY21
Key Achievements FY21 M&A Sales Up 95% ARR Up 80% New Talent Completed Achieved $25.6M of sales Grown CARR to $15.8M, Steve Parkes, CFO transformational orders, highest in Mach7 with annualized ARR David Madaffri, VP Sales acquisition of Client history (current run rate) Outlook at $13.4M Lisa Thomp
Slide 9: Impact to FY21 Outlook FY22
Impact to FY21 Outlook FY22 • Hospitals in the US faced • Hospital spending appears unprecedented financial to be back on track pressure • Staffing issues are on their • This in turn effected hospital way to recovery staffing and forced • Projects are being prioritized prioritization of projects for
Slide 10: Major expansion contract wins secured from Trinity Health and Advocate Aurora Healthcare
• Sales orders $16.2M (TCV); up 368% on last quarter (Q4’21 $4.4M) • Major expansion contract wins secured from Trinity Health and Advocate Aurora Healthcare • Contracted annual recurring revenue (CARR) $16.8M; up 6% (or 24% annualized) (Q4’21 $15.8M) • Cash on hand $18.5M; (30 June 2021 $18.4M) *To
Slide 11: FY22 Outlook
FY22 Outlook Financial Product Sales & Marketing Industry • $27M Revenue Target for • Fully integrated product • Springboard from an • Focused on Enterprise CY21 (previously roadmap by end of 1HFY22 exceptional FY21 Data Management, the announced on 10 June sales year backbone of an 2020) is On Trac
Slide 12: Organic Growth strategy
Organic Growth strategy Acquisitive Growth Strategy • Market transition from Radiology PACS • If we find opportunity that can fill focus to enterprise informatics focus. product gaps and/or provide great Mach7 VNA and Enterprise Viewer ideally value to our customers, we will suited for paradigm shif
Mach7 Technologies — Shareholder Meeting (November 2021) on 6ix